2483735-10-8
Chemical Structure
Dehydroepiandrosterone-13C3
- CAS No.: 2483735-10-8
- Formula:C1613C3H28O2
- Molecular Weight:291.40
IUPAC Name: (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[i]phenanthren-17-one-2,3,4-13C3
InChIKey: FMGSKLZLMKYGDP-UXANGDFNSA-N
SMILES: C[C@@]12[C@]3([H])[C@](CC=C1[13CH2][13C@H]([13CH2]C2)O)([H])[C@@]4([H])[C@](CC3)(C(CC4)=O)C
Biological Activity: Dehydroepiandrosterone-13C3 is a 13C-labeled and deuterium labeled Dehydroepiandrosterone[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Dehydroepiandrosterone-13C3 | Dehydroepiandrosterone-13C3 is a 13C-labeled and deuterium labeled Dehydroepiandrosterone. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DHEA (Standard) | 99.31% | DHEA (Prasterone) (Standard) is the analytical standard of DHEA. This product is intended for research and analytical applications. DHEA is a steroid hormone. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DHEA-d5 | DHEA-d5 (Prasterone-d5; Dehydroisoandrosterone-d5; Dehydroepiandrosterone-d5) is the deuterium labeled DHEA (HY-14650). DHEA (Prasterone) is one of the most abundant steroid hormones. DHEA (Prasterone) mediates its action via multiple signaling pathways involving specific membrane receptors and via transformation into androgen and estrogen derivatives (e.g., androgens, estrogens, 7α and 7β DHEA, and 7α and 7β epiandrosterone derivatives) acting through their specific receptors. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dehydroepiandrosterone-d6 | 99.90% | Dehydroepiandrosterone-d6 is the deuterium labeled Dehydroepiandrosterone. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DHEA | 99.94% | DHEA (Prasterone) is one of the most abundant steroid hormones. DHEA (Prasterone) mediates its action via multiple signaling pathways involving specific membrane receptors and via transformation into androgen and estrogen derivatives (e.g., androgens, estrogens, 7α and 7β DHEA, and 7α and 7β epiandrosterone derivatives) acting through their specific receptors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||